These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33718106)

  • 1. Predicting Metastasis Risk in Pancreatic Neuroendocrine Tumors Using Deep Learning Image Analysis.
    Klimov S; Xue Y; Gertych A; Graham RP; Jiang Y; Bhattarai S; Pandol SJ; Rakha EA; Reid MD; Aneja R
    Front Oncol; 2020; 10():593211. PubMed ID: 33718106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A CNN-based active learning framework to identify mycobacteria in digitized Ziehl-Neelsen stained human tissues.
    Yang M; Nurzynska K; Walts AE; Gertych A
    Comput Med Imaging Graph; 2020 Sep; 84():101752. PubMed ID: 32758706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Prognostic Significances of Cytokeratin 19 and KIT Expression in Surgically Resectable Pancreatic Neuroendocrine Tumors.
    Son EM; Kim JY; An S; Song KB; Kim SC; Yu E; Hong SM
    J Pathol Transl Med; 2015 Jan; 49(1):30-6. PubMed ID: 25812655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts.
    Fremond S; Andani S; Barkey Wolf J; Dijkstra J; Melsbach S; Jobsen JJ; Brinkhuis M; Roothaan S; Jurgenliemk-Schulz I; Lutgens LCHW; Nout RA; van der Steen-Banasik EM; de Boer SM; Powell ME; Singh N; Mileshkin LR; Mackay HJ; Leary A; Nijman HW; Smit VTHBM; Creutzberg CL; Horeweg N; Koelzer VH; Bosse T
    Lancet Digit Health; 2023 Feb; 5(2):e71-e82. PubMed ID: 36496303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review.
    Persano I; Parlagreco E; La Salvia A; Audisio M; Volante M; Buttigliero C; Scagliotti GV; Brizzi MP
    Semin Oncol; 2022 Dec; 49(6):476-481. PubMed ID: 36759234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic High-Grade Neuroendocrine Neoplasms in the Korean Population: A Multicenter Study.
    Kim H; An S; Lee K; Ahn S; Park DY; Kim JH; Kang DW; Kim MJ; Chang MS; Jung ES; Kim JM; Choi YJ; Jin SY; Chang HK; Cho MY; Kang YK; Kang M; Ahn S; Kim YW; Hong SM;
    Cancer Res Treat; 2020 Jan; 52(1):263-276. PubMed ID: 31319641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Eighth Edition of the American Joint Committee on Cancer Distant Metastases Stage Classification for Metastatic Pancreatic Neuroendocrine Tumors Might Be Feasible for Metastatic Pancreatic Ductal Adenocarcinomas.
    Wen J; Chen J; Liu D; Xu X; Fan M; Zhang Z
    Neuroendocrinology; 2020; 110(5):364-376. PubMed ID: 31357196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct clinicopathological and prognostic features of insulinoma with synchronous distant metastasis.
    Gao H; Wang W; Xu H; Wu C; Jin W; Zhang S; Xu J; Ni Q; Yu X; Liu L
    Pancreatology; 2019 Apr; 19(3):472-477. PubMed ID: 30850220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns and predictors of pancreatic neuroendocrine tumor prognosis: Are no two leaves alike?
    Gao H; Wang W; Yu X; Liu L
    Crit Rev Oncol Hematol; 2021 Nov; 167():103493. PubMed ID: 34653597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for short recurrence-free survival after resection of pancreatic neuroendocrine tumor (PanNET) liver metastases: which patients should undergo resection?
    Masui T; Nagai K; Anazawa T; Kasai Y; Sato A; Nakano K; Uchida Y; Yogo A; Kawaguchi Y; Takaori K; Uemoto S
    Scand J Gastroenterol; 2020 Apr; 55(4):479-484. PubMed ID: 32223573
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel risk factor panel predicts early recurrence in resected pancreatic neuroendocrine tumors.
    Wang WQ; Zhang WH; Gao HL; Huang D; Xu HX; Li S; Li TJ; Xu SS; Li H; Long J; Ye LY; Wu CT; Han X; Wang XH; Liu L; Yu XJ
    J Gastroenterol; 2021 Apr; 56(4):395-405. PubMed ID: 33742253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FAM83A promotes the progression and metastasis of human pancreatic neuroendocrine tumors by inducing the epithelial-mesenchymal transition via the PI3K/AKT and ERK pathways.
    Zhou B; Zhou X; Zhan C; Jin M; Yan S
    J Endocrinol Invest; 2023 Jun; 46(6):1115-1130. PubMed ID: 36344884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Threshold for Circulating Tumor Cells in Patients With Pancreatic and Midgut Neuroendocrine Tumors.
    Mandair D; Khan MS; Lopes A; Furtado O'Mahony L; Ensell L; Lowe H; Hartley JA; Toumpanakis C; Caplin M; Meyer T
    J Clin Endocrinol Metab; 2021 Mar; 106(3):872-882. PubMed ID: 33180939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical and in situ hybridization analyses of glucose transporter 2 in pancreatic neuroendocrine tumors: Possible glucose transporter 2 association with neoplastic insulin production.
    Watanabe H; Fujishima F; Unno M; Sasano H; Suzuki T
    Pathol Res Pract; 2024 Jan; 253():154966. PubMed ID: 38043192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a weakly supervised deep learning framework to predict the status of molecular pathways and key mutations in colorectal cancer from routine histology images: a retrospective study.
    Bilal M; Raza SEA; Azam A; Graham S; Ilyas M; Cree IA; Snead D; Minhas F; Rajpoot NM
    Lancet Digit Health; 2021 Dec; 3(12):e763-e772. PubMed ID: 34686474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosing pancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1 in daily practice.
    van Beek DJ; Pieterman CRC; Wessels FJ; van de Ven AC; de Herder WW; Dekkers OM; Zandee WT; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IHM; Vriens MR; Valk GD
    Front Endocrinol (Lausanne); 2022; 13():926491. PubMed ID: 36277719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Phosphohistone-H3-Assisted Mitotic Count and Ki67 Score in the Determination of Tumor Grade and Prediction of Distant Metastasis in Well-Differentiated Pancreatic Neuroendocrine Tumors.
    Ozturk Sari S; Taskin OC; Gundogdu G; Yegen G; Onder S; Keskin M; Saglam S; Ozluk Y; Gulluoglu M; Mete O
    Endocr Pathol; 2016 Jun; 27(2):162-70. PubMed ID: 26936845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of BRCA Gene Mutation in Breast Cancer Based on Deep Learning and Histopathology Images.
    Wang X; Zou C; Zhang Y; Li X; Wang C; Ke F; Chen J; Wang W; Wang D; Xu X; Xie L; Zhang Y
    Front Genet; 2021; 12():661109. PubMed ID: 34354733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep Learning Facilitates Distinguishing Histologic Subtypes of Pulmonary Neuroendocrine Tumors on Digital Whole-Slide Images.
    Ilié M; Benzaquen J; Tourniaire P; Heeke S; Ayache N; Delingette H; Long-Mira E; Lassalle S; Hamila M; Fayada J; Otto J; Cohen C; Gomez-Caro A; Berthet JP; Marquette CH; Hofman V; Bontoux C; Hofman P
    Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors.
    Singhi AD; Liu TC; Roncaioli JL; Cao D; Zeh HJ; Zureikat AH; Tsung A; Marsh JW; Lee KK; Hogg ME; Bahary N; Brand RE; McGrath KM; Slivka A; Cressman KL; Fuhrer K; O'Sullivan RJ
    Clin Cancer Res; 2017 Jan; 23(2):600-609. PubMed ID: 27407094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.